This inventor holds 1 USPTO granted patent. Top assignees: Children's Hospital Los Angeles, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 69 
1 out of 3,699 
Years Active: 2006
Title: The Innovative Contributions of Craig A. Mullen
Introduction
Craig A. Mullen is an influential inventor based in Sugar Land, Texas. He has made significant strides in the medical field, particularly in developing therapeutic methods for treating conditions in newborns. Mullen's pioneering work has yielded a patented invention that provides a crucial therapeutic effect through innovative cellular therapies.
Latest Patents
Mullen holds a patent for a method designed to provide therapeutic benefits to human patients by administering CD34+ cells derived from cord blood. This method involves engineering these cells with nucleic acid sequences that encode therapeutic agents. The innovative approach uses retroviral vectors to transduce the CD34+ cells, which can effectively treat newborn infants suffering from Adenosine Deaminase Deficiency (ADA deficiency). This groundbreaking patent demonstrates Mullen's commitment to advancing healthcare through cell therapy.
Career Highlights
Throughout his career, Craig A. Mullen has worked with esteemed organizations, including Children's Hospital of Los Angeles and the U.S. Department of Health and Human Services. His experience at these institutions has enriched his understanding of patient care and therapeutic innovations.
Collaborations
Mullen has collaborated with prominent figures in the medical research community, including Donald B. Kohn and R. Michael Blaese. These partnerships have fostered an environment of innovation and shared knowledge that has contributed to advancements in therapeutic methods utilizing engineered CD34+ cells.
Conclusion
Craig A. Mullen stands out as a key inventor in the realm of medical innovation. With a focus on cellular therapy, his patent is a testament to his dedication to improving health outcomes for vulnerable populations, particularly newborns affected by genetic disorders. His collaborations and career achievements continue to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile